Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer

Published:2018-12 Issue:3 Volume:151 Page:525-532
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Belur Nagaraj Anil,Joseph Peronne,Kovalenko Olga,Wang QuanQiu,Xu Rong,DiFeo Analisa^ORCID

Funder

National Cancer Institute

Department of Defense

Mary Kay Foundation

Young Scientist Foundation

National Institutes of Health

National Institute of Aging

American Cancer Society

Clinical and Translational Science Collaborative of Cleveland

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference30 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J. Clin.,2017

2. The resurgence of platinum-based cancer chemotherapy;Kelland;Nat. Rev. Cancer,2007

3. Evolution of platinum resistance in high-grade serous ovarian cancer;Cooke;Lancet Oncol.,2011

4. Drug repositioning: identifying and developing new uses for existing drugs;Ashburn;Nat. Rev. Drug Discov.,2004

5. Drug repurposing in oncology-patient and health systems opportunities;Bertolini;Nat. Rev. Clin. Oncol.,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dronedarone inhibits the proliferation of esophageal squamous cell carcinoma through the CDK4/CDK6-RB1 axis in vitro and in vivo;Frontiers of Medicine;2024-09-13

2. Drug repositioning and ovarian cancer, a study based on Mendelian randomisation analysis;Frontiers in Oncology;2024-04-08

3. Microfluidic production of amiodarone loaded nanoparticles and application in drug repositioning in ovarian cancer;Scientific Reports;2024-03-15

4. Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial–Mesenchymal Transition in an Ovarian Tumor;Journal of Natural Products;2024-02-28

5. Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization;Alzheimer's Research & Therapy;2021-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3